This inventor holds 1 USPTO granted patent. Top assignee: Sumika Fine Chemicals, Co.,ltd.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovative Mind of Yoshihiro Kawata
Introduction
Yoshihiro Kawata, an inventive researcher based in Osaka, Japan, has made significant contributions to the field of chemical processing. With a keen focus on enhancing pharmaceutical production methods, Kawata has secured a patent that offers a novel approach to drying paroxetine hydrochloride anhydrate.
Latest Patents
Kawata's single patent, titled "Method for drying anhydrous paroxetine hydrochloride," details a sophisticated process for efficiently drying this compound. The method involves reacting a paroxetine compound with hydrogen chloride in isopropyl alcohol and subsequently crystallizing the resulting product. Kawata's process not only reduces the amount of isopropyl alcohol remaining in the paroxetine hydrochloride anhydrate but also does so in a simplified manner, eliminating the need for large-scale apparatuses.
Career Highlights
Yoshihiro Kawata has become a representative figure in the pharmaceutical industry, particularly through his work at Sumika Fine Chemicals Co., Ltd. Here, he has played an essential role in innovating methods that enhance the efficiency and safety of pharmaceutical manufacturing processes.
Collaborations
Throughout his career, Kawata has collaborated with prominent colleagues such as Mitsuru Okatake and Taro Ishibashi. These partnerships have helped foster an environment of innovation and knowledge sharing, leading to advancements in their respective fields.
Conclusion
Yoshihiro Kawata’s dedication to improving pharmaceutical processes through innovative techniques exemplifies the spirit of invention. His patent reflects not only his ingenuity but also the potential benefits it holds for the industry. With continued efforts and collaborations, Kawata is likely to spur further advancements that will elevate pharmaceutical manufacturing practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile